• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过聚类分析确定的易加重成人哮喘患者的临床特征

Clinical Characteristics of Exacerbation-Prone Adult Asthmatics Identified by Cluster Analysis.

作者信息

Kim Mi Ae, Shin Seung Woo, Park Jong Sook, Uh Soo Taek, Chang Hun Soo, Bae Da Jeong, Cho You Sook, Park Hae Sim, Yoon Ho Joo, Choi Byoung Whui, Kim Yong Hoon, Park Choon Sik

机构信息

Department of Pulmonology, Allergy and Critical Care Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.

Genome Research Center for Allergy and Respiratory Diseases, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

出版信息

Allergy Asthma Immunol Res. 2017 Nov;9(6):483-490. doi: 10.4168/aair.2017.9.6.483.

DOI:10.4168/aair.2017.9.6.483
PMID:28913987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5603476/
Abstract

PURPOSE

Asthma is a heterogeneous disease characterized by various types of airway inflammation and obstruction. Therefore, it is classified into several subphenotypes, such as early-onset atopic, obese non-eosinophilic, benign, and eosinophilic asthma, using cluster analysis. A number of asthmatics frequently experience exacerbation over a long-term follow-up period, but the exacerbation-prone subphenotype has rarely been evaluated by cluster analysis. This prompted us to identify clusters reflecting asthma exacerbation.

METHODS

A uniform cluster analysis method was applied to 259 adult asthmatics who were regularly followed-up for over 1 year using 12 variables, selected on the basis of their contribution to asthma phenotypes. After clustering, clinical profiles and exacerbation rates during follow-up were compared among the clusters.

RESULTS

Four subphenotypes were identified: cluster 1 was comprised of patients with early-onset atopic asthma with preserved lung function, cluster 2 late-onset non-atopic asthma with impaired lung function, cluster 3 early-onset atopic asthma with severely impaired lung function, and cluster 4 late-onset non-atopic asthma with well-preserved lung function. The patients in clusters 2 and 3 were identified as exacerbation-prone asthmatics, showing a higher risk of asthma exacerbation.

CONCLUSIONS

Two different phenotypes of exacerbation-prone asthma were identified among Korean asthmatics using cluster analysis; both were characterized by impaired lung function, but the age at asthma onset and atopic status were different between the two.

摘要

目的

哮喘是一种具有多种类型气道炎症和阻塞特征的异质性疾病。因此,使用聚类分析可将其分为几种亚表型,如早发型特应性、肥胖非嗜酸性粒细胞性、良性和嗜酸性粒细胞性哮喘。许多哮喘患者在长期随访期间经常出现病情加重,但聚类分析很少评估易加重的亚表型。这促使我们识别反映哮喘加重的聚类。

方法

采用统一的聚类分析方法,对259名成年哮喘患者进行分析,这些患者接受了超过1年的定期随访,使用基于对哮喘表型的贡献而选择的12个变量。聚类后,比较各聚类之间的临床特征和随访期间的加重率。

结果

识别出四种亚表型:聚类1由肺功能保留的早发型特应性哮喘患者组成,聚类2为肺功能受损的晚发型非特应性哮喘患者,聚类3是肺功能严重受损的早发型特应性哮喘患者,聚类4为肺功能良好的晚发型非特应性哮喘患者。聚类2和3中的患者被确定为易加重的哮喘患者,显示出更高的哮喘加重风险。

结论

通过聚类分析在韩国哮喘患者中识别出两种不同的易加重哮喘表型;两者均以肺功能受损为特征,但两者之间哮喘发病年龄和特应性状态不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b8/5603476/3f49016631f8/aair-9-483-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b8/5603476/b85d1affeb66/aair-9-483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b8/5603476/7c4bcbda24dc/aair-9-483-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b8/5603476/3f49016631f8/aair-9-483-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b8/5603476/b85d1affeb66/aair-9-483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b8/5603476/7c4bcbda24dc/aair-9-483-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97b8/5603476/3f49016631f8/aair-9-483-g003.jpg

相似文献

1
Clinical Characteristics of Exacerbation-Prone Adult Asthmatics Identified by Cluster Analysis.通过聚类分析确定的易加重成人哮喘患者的临床特征
Allergy Asthma Immunol Res. 2017 Nov;9(6):483-490. doi: 10.4168/aair.2017.9.6.483.
2
Phenotypes Determined by Cluster Analysis in Moderate to Severe Bronchial Asthma.中度至重度支气管哮喘中通过聚类分析确定的表型
Folia Med (Plovdiv). 2017 Jun 1;59(2):165-173. doi: 10.1515/folmed-2017-0031.
3
Heterogeneity of Childhood Asthma in Korea: Cluster Analysis of the Korean Childhood Asthma Study Cohort.韩国儿童哮喘的异质性:韩国儿童哮喘研究队列的聚类分析
Allergy Asthma Immunol Res. 2021 Jan;13(1):42-55. doi: 10.4168/aair.2021.13.1.42.
4
Common exacerbation-prone phenotypes across asthma and chronic obstructive pulmonary disease (COPD).哮喘和慢性阻塞性肺疾病(COPD)共有的易恶化表型。
PLoS One. 2022 Mar 21;17(3):e0264397. doi: 10.1371/journal.pone.0264397. eCollection 2022.
5
Features of asthma which provide meaningful insights for understanding the disease heterogeneity.哮喘的特征为理解疾病异质性提供了有意义的见解。
Clin Exp Allergy. 2018 Jan;48(1):39-47. doi: 10.1111/cea.13014. Epub 2017 Sep 15.
6
Asthma Phenotypes Defined From Parameters Obtained During Recovery From a Hospital-Treated Exacerbation.从医院治疗的哮喘恶化中恢复期间获得的参数定义的哮喘表型。
J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):1960-1967. doi: 10.1016/j.jaip.2018.02.012. Epub 2018 Mar 1.
7
Cluster analysis and clinical asthma phenotypes.聚类分析与临床哮喘表型
Am J Respir Crit Care Med. 2008 Aug 1;178(3):218-224. doi: 10.1164/rccm.200711-1754OC. Epub 2008 May 14.
8
A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype.一种聚类方法,用于确定和描述哮喘和慢性阻塞性肺疾病重叠表型。
Clin Exp Allergy. 2017 Nov;47(11):1374-1382. doi: 10.1111/cea.12970. Epub 2017 Aug 1.
9
Peripheral blood transcriptomic clusters uncovered immune phenotypes of asthma.外周血转录组簇揭示了哮喘的免疫表型。
Respir Res. 2022 Sep 8;23(1):237. doi: 10.1186/s12931-022-02156-w.
10
Cluster Analysis on Longitudinal Data of Patients with Adult-Onset Asthma.患者成人发病哮喘纵向数据的聚类分析。
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):967-978.e3. doi: 10.1016/j.jaip.2017.01.027. Epub 2017 Apr 25.

引用本文的文献

1
Computational Phenotyping of Obstructive Airway Diseases: A Systematic Review.阻塞性气道疾病的计算表型分析:一项系统综述
J Asthma Allergy. 2025 Feb 6;18:113-160. doi: 10.2147/JAA.S463572. eCollection 2025.
2
A Roadmap for Using Causal Inference and Machine Learning to Personalize Asthma Medication Selection.使用因果推断和机器学习实现哮喘药物个性化选择的路线图。
JMIR Med Inform. 2024 Apr 17;12:e56572. doi: 10.2196/56572.
3
Leptin/obR signaling exacerbates obesity-related neutrophilic airway inflammation through inflammatory M1 macrophages.

本文引用的文献

1
Periostin in Exhaled Breath Condensate and in Serum of Asthmatic Patients: Relationship to Upper and Lower Airway Disease.哮喘患者呼出气冷凝液和血清中的骨膜蛋白:与上、下气道疾病的关系
Allergy Asthma Immunol Res. 2017 Mar;9(2):126-132. doi: 10.4168/aair.2017.9.2.126.
2
Development of New Therapies for Severe Asthma.重度哮喘新疗法的研发
Allergy Asthma Immunol Res. 2017 Jan;9(1):3-14. doi: 10.4168/aair.2017.9.1.3.
3
Measuring Eosinophils to Make Treatment Decisions in Asthma.测量嗜酸性粒细胞以指导哮喘治疗决策
瘦素/ob 受体信号通过炎症 M1 巨噬细胞加剧肥胖相关的中性粒细胞性气道炎症。
Mol Med. 2023 Jul 24;29(1):100. doi: 10.1186/s10020-023-00702-w.
4
Association of genetic variants of oxidative stress responsive kinase 1 (OXSR1) with asthma exacerbations in non-smoking asthmatics.氧化应激反应激酶 1(OXSR1)的遗传变异与非吸烟哮喘患者哮喘加重的关联。
BMC Pulm Med. 2022 Jan 4;22(1):3. doi: 10.1186/s12890-021-01741-x.
5
A Systematic Review of Asthma Phenotypes Derived by Data-Driven Methods.数据驱动方法衍生的哮喘表型的系统评价
Diagnostics (Basel). 2021 Apr 2;11(4):644. doi: 10.3390/diagnostics11040644.
6
Challenges of Clustering Multimodal Clinical Data: Review of Applications in Asthma Subtyping.多模态临床数据聚类的挑战:哮喘亚型分类中的应用综述
JMIR Med Inform. 2020 May 28;8(5):e16452. doi: 10.2196/16452.
7
Innate Lymphoid Cells in the Airways: Their Functions and Regulators.气道中的固有淋巴细胞:其功能与调节因子
Allergy Asthma Immunol Res. 2020 May;12(3):381-398. doi: 10.4168/aair.2020.12.3.381.
8
Exacerbation-Prone Asthma.易恶化型哮喘。
J Allergy Clin Immunol Pract. 2020 Feb;8(2):474-482. doi: 10.1016/j.jaip.2019.11.009. Epub 2019 Nov 22.
9
Association Between Epithelial Cytokines and Clinical Phenotypes of Elderly Asthma.上皮细胞因子与老年哮喘临床表型之间的关联
Allergy Asthma Immunol Res. 2019 Jan;11(1):79-89. doi: 10.4168/aair.2019.11.1.79.
10
Characteristics of Adult Severe Refractory Asthma in Korea Analyzed From the Severe Asthma Registry.韩国成人重度难治性哮喘的特征:基于重度哮喘登记处的分析
Allergy Asthma Immunol Res. 2019 Jan;11(1):43-54. doi: 10.4168/aair.2019.11.1.43.
Chest. 2016 Sep;150(3):485-7. doi: 10.1016/j.chest.2016.07.009.
4
Using Periostin as a Biomarker in the Treatment of Asthma.将骨膜蛋白用作哮喘治疗的生物标志物。
Allergy Asthma Immunol Res. 2016 Nov;8(6):491-8. doi: 10.4168/aair.2016.8.6.491.
5
Mepolizumab treatment in patients with severe eosinophilic asthma.美泊利珠单抗治疗严重嗜酸性粒细胞性哮喘患者。
N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8.
6
Clinical significance of asthma clusters by longitudinal analysis in Korean asthma cohort.纵向分析韩国哮喘队列中哮喘簇的临床意义。
PLoS One. 2013 Dec 31;8(12):e83540. doi: 10.1371/journal.pone.0083540. eCollection 2013.
7
Adult asthma biomarkers.成人哮喘生物标志物。
Curr Opin Allergy Clin Immunol. 2014 Feb;14(1):49-54. doi: 10.1097/ACI.0000000000000028.
8
Three phenotypes of adult-onset asthma.三种成人发病哮喘表型。
Allergy. 2013;68(5):674-80. doi: 10.1111/all.12136.
9
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.探讨奥马珠单抗对过敏性哮喘的影响:EXTRA 研究中的生物标志物分析。
Am J Respir Crit Care Med. 2013 Apr 15;187(8):804-11. doi: 10.1164/rccm.201208-1414OC.
10
Identification of subtypes of refractory asthma in Korean patients by cluster analysis.通过聚类分析鉴定韩国患者难治性哮喘的亚型。
Lung. 2013 Feb;191(1):87-93. doi: 10.1007/s00408-012-9430-8. Epub 2012 Nov 10.